MaryL.StedmanMD

Psychiatry • Tampa, FL

Child & Adolescent Psychiatry, Forensic Psychiatry, Geriatric Psychiatry, Neuropsychiatry

Stedman Clinical Trials

Join to view full profile

Dr. Stedman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stedman's full profile

Already have an account?

Office
14506 University Point Pl
Tampa, FL 33613
Phone+1 813-971-8311

Fax+1 813-971-0862

Summary

Dr. Mary Stedman is a psychiatrist in Tampa, FL. She received her medical degree from University of South Florida College of Medicine and has been in practice 30 years. She specializes in geriatric psychiatry and neuropsychiatry and is experienced in transcranial magnetic stimulation.

Education & Training

University of South Florida MorsaniFellowship, Child and Adolescent Psychiatry, 1987 - 1992
University of South Florida MorsaniResidency, Psychiatry, 1987 - 1990
University of South Florida College of MedicineClass of 1987

Certifications & Licensure

FL State Medical License 1979 - 2027
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females Start of enrollment: 2007 Oct 01
Unknown status
Phase 2, Phase 3
Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression Start of enrollment: 2010 Nov 01
Completed
Phase 2
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Completed
Phase 2, Phase 3
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01
Completed
Phase 3
Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01
Completed
Phase 3
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01
Completed
Phase 3
A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) Start of enrollment: 2016 Oct 29
ACTIVE_NOT_RECRUITING
Simufilam 100 Mg for Mild-to-Moderate Alzheimer's Disease Start of enrollment: 2021 Nov 03
COMPLETED
PHASE3
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial.
Charles R Conway, Scott T Aaronson, Harold A Sackeim, Mark S George, John Zajecka
Brain Stimulation. 2024-12-18
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
Charles R Conway, Scott T Aaronson, Harold A Sackeim, Walter Duffy, Mary Stedman
Brain Stimulation. 2024-04-02
48 citations
A Double-Blind, Placebo-Controlled Study With Quetiapine as Adjunct Therapy With Lithium or Divalproex in Bipolar I Patients With Coexisting Alcohol Dependence
Mary Stedman, Helen M. Pettinati, E. Sherwood Brown, Margaret M. Kotz, Joseph R. Calabrese
Alcoholism, Clinical and Experimental Research. 2010-10-01